US-based non-profit healthcare system Intermountain Healthcare has selected PierianDx Clinical Genomics Workstation to advance its precision medicine programme ‘Intermountain Precision Genomics’.

Intermountain Healthcare will utilise PierianDx for next-generation sequencing (NGS) variant analysis and reporting services to help explore new targeted therapies and provide potential clinical trial opportunities for patients with cancer.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

PierianDx CEO Michael Sanderson said: “We are thrilled that Intermountain Healthcare has joined our rapidly expanding partner network.

“Intermountain Healthcare is widely known as a leader in precision medicine and we look forward to continued collaboration opportunities.”

Under the partnership, PierianDx provides a SaaS platform and Clinical Genomics Workspace (CGW), an integrated workspace for genomic analytics, classification, interpretation and reporting.

It also provides the clinical software for informatics, interpretation and reporting of NGS data to Intermountain Healthcare.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Intermountain Healthcare can access the genomic data within CGW’s knowledgebase through PierianDx’s customer network.

CGW comprises millions of biomedical findings driven by public and highly curated sources.

Using PierianDx’ clinical genomics solution, Intermountain Healthcare joins other leading diagnostic labs and health systems.

PierianDx’s CGW offers complete informatics, genomic interpretation, and reporting workflow support for cancer and germline molecular diagnostic testing applications.

Established in 2014, PierianDx is engaged in advancing cancer diagnostics and making targeted therapeutics more accessible to healthcare systems and laboratories across the world.

CAP and CLIA clinical genomics technologies of the company deliver the most integrated approach across the clinical care spectrum.

Intermountain Precision Genomics targets treatments aimed at delivering quality care at some of the lowest costs in the nation.

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
YPrime won the Innovation award for AI in Clinical Trials and the Environmental award for Sustainable Trials, thanks to its eCOA, IRT and eConsent platforms. Explore how purpose-built AI, paperless workflows and circular hardware practices are reshaping timelines, data quality and ESG performance in clinical research.

Discover the Impact